Enhanced kinetic extraction of parvovirus B19 structural proteins

Biotechnology and Bioengineering

Volumn 80, Issue 3, 2002, Pages 250-256

  Sico, Colleen ^a   White, Stephen ^a   Tsao, Eric ^a   Varma, Amit ^a  

^a MEDIMMUNE   (United States)

Author keywords

B19; Extraction; Parvovirus; Virus like particle (VLP)

Indexed keywords

CELLS; DETERGENTS; EXTRACTION; OPTIMIZATION; PROTEINS; VACCINES;

SOLUBILIZATIONS;

BIOTECHNOLOGY;

DETERGENT; REDUCING AGENT; SODIUM CHLORIDE; STRUCTURAL PROTEIN; VACCINE;

ARTICLE; BACULOVIRUS; DIFFUSION; EXTRACTION; HIGH TEMPERATURE; KINETICS; PARVOVIRUS; PH; SOLUBILIZATION; ULTRASOUND; VIRUS EXPRESSION; VIRUS PARTICLE;

ANIMALS; BACULOVIRIDAE; CAPSID; CAPSID PROTEINS; CELLS, CULTURED; GENE EXPRESSION; HUMANS; HYDROGEN-ION CONCENTRATION; INSECTS; QUALITY CONTROL; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TEMPERATURE;

PARVOVIRUS; UNIDENTIFIED BACULOVIRUS;

EID: 0037027381     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.10509     Document Type: Article

References (24)

1. Bansal GP, Hatfield JA, Dunn FE, Kramer AA, Brady F, Riggin CH, Collett MS, Yoshimoto K, Young NS. 1993. Candidate recombinant vaccine for human B19 parvovirus. J Infect Dis 167:1034-1044.
2. Betenbaugh M, Yu M, Kuehl K, White J, Pennock D, Spik K, Schmaljohn C. 1995. Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus. Virus Res 38:111-124.
3. Brown CS, Salimans MM, Noteborn MH, Weiland HT. 1990. Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Res 15:197-211.
4. Brown KE, Young NS, Johnson ML. 1994. Molecular, cellular and clinical aspects of Parvovirus B19 infection. Crit Rev Oncol Hematol 16:1-31.
5. Cruz PE, Cunha A, Peixoto CC, Clemente J, Moreira JL, Carrondo MJ. 1998. Optimization of the production of virus-like particles in insect cells. Biotechnol Bioeng 60:408-418.
6. Damhof RA, Feijlbrief M, Welling-Wester S, Welling GW. 1994. Purification of the integral membrane glycoproteins D of herpes simplex virus 1 and 2, produced in the recombinant baculovirus expression system, by ion-exchange high-performance liquid chromatography. J Chromatogr A 676:43-49.
7. Donaldson MS, Shuler ML. 1998. Low-cost serum-free medium for the BT1-Tn5B1-4 insect cell line. Biotechnol Progr 14:573-579.
8. Ferrance JP, Goel A, Ataai MM. 1992. Utilization of glucose and amino acids in insect cell cultures: Quantifying the metabolic flows within the primary pathways and medium development. Biotechnol Bioeng 42:697-707.
9. George HJ, Van Dyk DE, Straney RA, Trzaskos JM, Copeland RA. 1996. Expression purification and characterization of recombinant human inducible prostaglandin G/H synthase from baculovirus-infected insect cells. Prot Expr Purif 7:19-26.
10. Hu YC, Bentley WE. 1999. Enhancing yield of infectious Bursal disease virus structural proteins in baculovirus expression systems: Focus on media, protease inhibitors, and dissolved oxygen. Biotechnol Progr 15:1065-1071.
11. Jiang B, Barniak V, Smith RP, Sharma R, Corasro B, Hu B, Madore HP. 1998. Synthesis of the rotavirus-like particles in insect cells: Comparative and quantitative analysis. Biotechnol Bioeng 60:369-374.
12. Juarbe-Osorio LG, Gorziglia M, Betenbaugh MJ. 1993. Recovery and characterization of a rotavirus outer capsid protein expressed in a recombinant insect cell system. Prot Expr Purif 4:232-239.
13. Kajigaya S, Fujii H, Field AM, Anderson S, Rosenfeld S, Anderson LJ, Shimada T, Young NS. 1991. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci USA 88:4646-4650.
14. Kajigaya S, Shimada T, Fujita S, Young NS. 1989. A genetically engineered cell line that produces empty capsids of B 19 (human) parvovirus. Proc Natl Acad Sci USA 86:7601-7605.
15. Pattison JR. 1988. Parvoviruses and Human Disease. Boca Raton, FL: CRC Press.
16. Rosenfeld SJ, Young NS, Alling D, Ayub J, Saxinger C. 1994. Subunit interaction in B19 parvovirus empty capsids. Arch Virol 136:9-18.
17. Rossmann MG, Johnson JE. 1989. Isohedral RNA virus structure. Annu Rev Biochem 58:533-573.
18. Sali DL, Ingram R, Wendel M. Gupta D, McNemar C, Tsarbopoulos A, Chen JW, Hong Z, Chase R, Risano C, Zhang R, Yao N, Kwong AD, Ramanathan L, Le HV, Weber PC. 1998. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex. Biochemistry 37:3392-3401.
19. Shuler ML, Cho T, Wickham T, Ogonah O, Kool M, Hammer DA, Granados RR, Wood HA. 1990. Bioreactor development for production of viral pesticides or heterologous proteins in insect cell cultures. Ann NY Acad Sci 589:399-422.
20. Tattersall P, Cotmore S. 1988. The nature of parvoviruses. In: Pattison JR, editor. Parvoviruses and Human Disease. Boca Raton, FL: CRC Press. p 5-41.
21. Tsao EI, Mason MR, Cacciuttolo MA, Bowen SH, Folena-Wasserman G. 1996. Production of parvovirus B19 vaccine in insect cells co-infected with double baculoviruses. Biotechnol Bioeng 49:130-138.
22. Wang M, Kwong S, Bentley WE. 1993. Effects of oxygen/glucose/glutamine feeding on insect cell baculovirus protein expression: A study on epoxide hydrolase production. Biotechnol Progr 9:355-361.
23. Welling-Wester S, Feijlbrief M, Koedijk D, Welling GW. 1998. Detergent extraction of herpes simplex virus type 1 glycoprotein D by zwitterionic and non-ionic detergents and purification by ion-exchange high-performance liquid chromatography. J Chromatogr A 816:29-37.
24. Young NS. 1988. Hematologic and hematopoietic consequences of B19 parvovirus infection. Sem Hematol 25:159-172.